Display:

Keyword Search: Prove
1 Article
Source: Global News

First postpartum depression drug for women approved in U.S.

Thursday 16:21 GMT

The U.S. Food and Drug Administration has approved the first drug specifically developed for severe depression after childbirth.

In a company-funded study of new mothers with moderate or severe postpartum depression, half the women given Zulresso had depression end within two-and-a-half days, about double the rate of those in a comparison group given dummy treatments. Whether the treatment gets covered by insurance is determined by each insurance company, which also sets the out-of-pocket costs, depending on the plan.


“Four hostile newspapers are more to be feared than a thousand bayonets...” ― Napoléon Bonaparte